| 영문 | cystic fibrosis | 한글 | 낭성섬유증 |
|---|---|---|---|
| 설명 | 유전병의 하나로 땀샘, 기관지에서 점액을 분비하는 샘, 이자등의 외분비샘(몸 밖으로 액체를 분비하는 샘. 내분비샘을 제외한 모든 샘을 이른다)의 이상을 특징으로 하는 병이다. 중요한 병적인 변화는 주로 기관지에서 점액을 분비하는 분비샘에서 지나치게 점도가 높은 점액이 분비되어 기관지를 막아 호흡장애를 일으키는 폐의 병터이며, 땀에서 과도한 전해질 특히 염화나트륨(NaCl)이 분비되어 몸에 전해질이 부족하게 된다. 또 이자의 소화액을 분비하는 분비샘의 이상으로 이자관이 막히거나 이자의 기능이 떨어져서 소화의 장애를 일으키기도 한다. 유태계에 많으며 우리나라에는 아주 드물다. |
||
| 영문 | heart-lung machine | 한글 | 심장-허파 기계 |
|---|---|---|---|
| 설명 | 심장의 수술에 사용되는 기계로서 심장이 수술을 받고 있는 동안 기능을 하지 못하므로 이 기능을 대신 해주는 기계이다. 이것은 대정맥과 대동맥사이에 연결이 되어서 혈액을 강제로 순환시키면서 대정맥에서 온 피에 산소를 공급하여 대동맥으로 돌려 보내는 역할을 한다. 즉 심장과 폐의 역할을 동시에 하는 기계이다. |
||
| 영문 | total lung capacity | 한글 | 전폐용량, 온허파용량 |
|---|---|---|---|
| 설명 | 폐활량(가능한 한 깊게 들여 마신 시점부터 천천히 한껏 내쉰 용량)에 잔기량(최대 날숨위치에서 폐내에 남은 용량. 약 1,200mL)을 합한 것이다. 건강한 성인은 6,000~7,000mL. 폐기종, 만성 기관지염 등의 폐색성 장애로 증가하게 되는 한편 허파섬유증, 무기폐, 흉수, 흉곽변형 등의 구속성 장애로 감소한다. |
||
| 영문 | lung cancer | 한글 | 폐암 |
|---|---|---|---|
| 설명 | 허파에 생기는 악성종양이다. 가장 예후가 나쁜 종양중의 하나로써 조기발견이 어렵고 증세 또한 늦게 나타나서, 그 종양의 종류에 따라 다르나 치료후에도 대개 8%만이 5년 생존이 가능한 악성종양이다. 유발인자로는 대표적으로 담배가 알려져 있으며, 유전적인 요소도 어느 정도 기여하는 것으로 알려져 있다. |
||
| 영문 | infectious disease | 한글 | 감염병 |
|---|---|---|---|
| 설명 | 바이러스로부터 기생충 크기까지의 생물을 원인으로 하는 병. 원인은 접촉전염성이며, 병원에서 감염되는 경우도 있다. 감염을 원인균에 따라 분류하면 바이러스, 세균, 클라미디아, 리켓차, 미코박테리움, 곰팡이, 원충, 윤충, 외부기생충 감염으로 나눌 수 있다. |
||
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
|---|---|
| HD | Haab-Dimmer [syndrome]; Hajna-Damon [broth]; Hansen disease; hearing distance; heart disease; helix ... |
| MD | Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major... |
| CFF | critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F... |
| CFP | chronic false positive; Clinical Fellowship Program; cyclophosphamide, fluorouracil, prednisone; cys... |
| CCAM | Congenital cystic adenomatoid malformation of the lung |
|---|---|
| ACDK | Acquired cystic disease of the kidney |
| ACKD | Acquired cystic kidney disease |
| ARCD | Acquired renal cystic disease |
| GCDFP-15 | Gross Cystic Disease Fluid Protein |
| cystic adenomatoid malformation of lung | <radiology> Only true pulmonary cystic disease of newborn, three X-ray types: multicystic, walls of varying thickness, multicystic, one large dominant thin-walled cyst, solid, mediastinal shift common, cysts often contain foetal lung fluid, Treatment: surgery Cf: congenital lobar emphysema (12 Dec 1998) |
|---|---|
| cystic adenomatoid malformation of lung, congenital | A developmental anomaly that usually becomes apparent in the neonatal period with progressive respiratory distress. This malformation is a focal pulmonary dysplasia characterised by a multicystic mass of terminal bronchiolar structures. Ccam is classified into 3 separate types (I, II, III) depending on cyst size. (12 Dec 1998) |
| medullary cystic disease | <disease> A rare hereditary kidney disease characterised by the gradual loss of kidney function due to the presence of cysts in the renal medulla. Symptoms include high urine output (cannot concentrate the urine), weakness, weight loss, nocturia, fatigue and headache. There is no cure and usually progresses from chronic renal failure to end stage renal disease. (27 Sep 1997) |
| medullary cystic kidney disease | <radiology> Mode of inheritance uncertain, usually affects young adults (early 20s), associated with red or blond hair (!!), causes salt wasting, polyuria, azotaemia, affects both kidneys, with progressive disease patients need dialysis or transplant (12 Dec 1998) |
| cystic disease of renal medulla | Presence of small cysts in the renal medulla associated with anaemia, sodium depletion, and chronic renal failure. It is of two types: 1) fatal autosomal recessive or juvenile type (also called familial juvenile nephrophthisis), beginning at about age 10 with an average duration of 6 to 8 years; 2) autosomal dominant or adult type, beginning at about age 30 but with a more fulminant course. Synonym: microcystic disease of renal medulla. (05 Mar 2000) |
| ovarian cystic disease | <gynaecology> A painful condition associated with the recurrent formation of large ovarian cysts. Distention of the ovarian capsule causes pain and rupture of a larger cyst can, in rare instances, cause internal bleeding. Treatment often includes hormone manipulation (birth control pills). (05 Jan 1998) |
| apical interstitial lung disease | <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs. Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection. (25 Jun 1999) |
| asbestos lung disease | <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy (12 Dec 1998) |
| basilar interstitial lung disease | <radiology> B bronchiectasis, A asbestosis, D drugs / DIP, L lymphangitic metastasis / LAM, A aspiration, S sarcoidosis, S scleroderma (12 Dec 1998) |
| parasitic eosinophilic lung disease | <radiology> All are metazoans (mostly nematodes), Ascaris, Strongyloides, Ancyclostoma, Schistosoma, tropical pulmonary eosinophilia, pulmonary larva migrans (12 Dec 1998) |
| rheumatoid lung disease | <radiology> Pleural effusion, most common finding, seen mostly in males (although RA more common in females), diffuse interstitial fibrosis, necrobiotic nodules, Caplan syndrome, nodules and pneumoeritis and hypertension (12 Dec 1998) |
| drug-induced eosinophilic lung disease | <radiology> Diffuse reticular pattern: nitrofurantoin, Loeffler-like pattern: penicillin, sulfonamides, ASA, para-ASA, imipramine, HCTZ, cromolyn sodium see: eosinophilic lung disease (12 Dec 1998) |
| interstitial lung disease | <chest medicine> A group of lung disorders which result in scarring and dysfunction of the alveolus (air sac) in the lung. This results in poor oxygen diffusion from the air into the bloodstream. Widespread inflammation in the lung leads to fibrosis (scarring). Causes include chronic exposure to organic and inorganic dusts, fumes, vapors, radiation, medications and certain lung infections. Examples include asbestosis, silicosis, coal worker's pneumoconiosis and diffuse interstitial fibrosis. Smoking increases the risk in all cases. (27 Sep 1997) |
| interstitial lung disease with increased volume | <radiology> Cystic fibrosis (CF), eosinophilic granuloma (EG), lymphangioleiomyomatosis (LAM) (12 Dec 1998) |
| obstructive lung disease | <chest medicine> A form of lung disease that manifests as acute or chronic, narrowing or blockage of the smaller airways in the lungs, causing increased resistance to airflow in the bronchial tubes (for example asthma, silicosis, chronic obstructive pulmonary disease from smoking). (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|